Analytik Jena AG Successfully Completes Capital Increase
September 20, 2013
Jena (Germany) – Today, Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) announced the successful completion of the cash capital increase with subscription rights of shareholders approved on September 4, 2013. As a result of the capital increase, all of the 1,950,232 new, no-par-value bearer shares were placed at a subscription price of EUR 12.50 [...]
Life Technologies Expands Presence in Russia with State-of-the-Art Customer Experience Centre
September 20, 2013
GLASGOW, Scotland -- Life Technologies Corporation (NASDAQ: LIFE) today announced the opening of its first Customer Experience Centre in Russia in partnership with Khimexpert, an authorized distributor of the company, providing customers with access to the latest cutting-edge technology. Located in Moscow, the center is equipped with the most advanced genetic analysis systems and qualified [...]
Jury Returns Verdict in RTI vs. BD Lawsuit
September 20, 2013
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that a jury has returned a mixed verdict in the lawsuit filed against the Company by Retractable Technologies, Inc. (RTI) in the United States Court for the Eastern District of Texas. The verdict was unfavorable to BD with respect to RTI's Lanham [...]
Enzo Life Sciences Expands Its Epigenetics Portfolio to Include DNA Methylation Analysis
September 20, 2013
Enzo Life Sciences is an established leader within the epigenetics market, providing pioneering Fluor de Lys™ kits for detection of histone modifications. As the field of epigenetics expands, Enzo Life Sciences is poised to maintain this leadership position by meeting the growing demand for more efficient and sensitive assay platforms for DNA methylation analysis, including [...]
INDI MOLECULAR LAUNCHES WITH $1.5 MILLION SEED ROUND LED BY INTERWEST PARTNERS
September 20, 2013
SEATTLE and CULVER CITY, CA – Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised a $1.5 million seed round led by InterWest Partners and joined by several angel investors. The funds will be used to further develop PCC (protein catalyzed capture) agent technology: a breakthrough process that produces [...]
SeraCare Life Sciences Expands R&D Facilities
September 20, 2013
MILFORD, Mass. -- SeraCare Life Sciences, a manufacturer of life sciences tools, bulk plasma, and quality controls for diagnostic companies and clinical laboratories, announced an expansion of its research and manufacturing facilities at its Milford, Massachusetts headquarters. The addition of the state-of-the-art facility was driven by new companion diagnostic manufacturing opportunities with key diagnostic partners [...]
September 19, 2013
FARMINGDALE, N.Y. -- Cemtrex (OTC: CTEI) announced it signed a distribution agreement for process oil and gas analyzer systems, in the U.S. market, with SensEvolution® a division of BAGGI®. This signing comes at a favorable time as the U.S. continues to expand its domestic oil production. Increasing production of crude oil from shale deposits in [...]
September 19, 2013
CREEDMOOR, NORTH CAROLINA – AirClean® Systems microprocessor-controlled PCR workstations reduce risk of sample contamination during DNA/RNA amplification. AirClean® Systems AC600 Series PCR workstations are designed as application solutions for the manipulation and amplification of DNA and RNA. These PCR workstations are available in 24’’, 32’’, and 48’’ widths. Additional features include built-in 254 nm ultraviolet [...]
Agilent Technologies to Separate into Two Industry-Leading Public Companies
September 19, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced plans to separate into two publicly traded companies: one in life sciences, diagnostics and applied markets (LDA) that will retain the Agilent name, and the other that will be comprised of Agilent's current portfolio of electronic measurement (EM) products. The separation is expected to [...]
September 19, 2013
REDWOOD CITY, Calif. -- Illumina, Inc. (NASDAQ: ILMN) today announced Verinata Health, an Illumina company, published additional peer-reviewed data1 showing that Verinata's non-invasive verifi® prenatal test2 correctly detects aneuploidies across all test samples, even for patients with very low fetal fractions (cell-free DNA fragments in maternal blood contributed from the fetus). The publication also documented [...]

